Jad Abdelsattar, Breast Surgical Oncologist at Banner Health, shared on X/Twitter:
”Excellent session this morning. Best papers of 2023. Some evidence to suggest that it might be acceptable to omit RT post-BCS in low-grade, small, and clinically node-negative breast cancers in older patients with ER high tumors who commit to 5 years of Endo treatment! ”
Source: Jad Abdelsatta/X